Bacterial persistence in vivo: resistance or tolerance to antibiotics.

J. F. Acar, L. D. Sabath

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The in vivo persistence of bacteria in spite of "adequate" therapy may be due to a variety of causes or factors. The most "obvious" cause is the presence of drug resistant strains, missed in conventional testing because of heterogeneity of resistance, special test requirements or emergence during treatment. A second large group of causes is due to atypical forms, whereas a third cause is due to tolerance. A fourth group of causes may be termed invironmental factors, and this includes drug inactivation, bioconversion or antagonism, often a result of the infection itself. [References: 55]
Original languageEnglish (US)
Pages (from-to)86-91
Number of pages6
JournalScandinavian Journal of Infectious Diseases Supplement
Volume14
Issue number14
StatePublished - 1978

Fingerprint

Anti-Bacterial Agents
Pharmaceutical Preparations
Bacteria
Infection
Therapeutics

Keywords

  • Animals
  • Anti-Bacterial Agents/me [Metabolism]
  • Anti-Bacterial Agents/tu [Therapeutic Use]
  • Bacteria/en [Enzymology]
  • Bacterial Infections/dt [Drug Therapy]
  • Biotransformation
  • Drug Resistance, Microbial
  • Humans
  • L Forms

Cite this

Bacterial persistence in vivo : resistance or tolerance to antibiotics. / Acar, J. F.; Sabath, L. D.

In: Scandinavian Journal of Infectious Diseases Supplement, Vol. 14, No. 14, 1978, p. 86-91.

Research output: Contribution to journalArticle

@article{3672fb8e821141009f5abd85df6b6f86,
title = "Bacterial persistence in vivo: resistance or tolerance to antibiotics.",
abstract = "The in vivo persistence of bacteria in spite of {"}adequate{"} therapy may be due to a variety of causes or factors. The most {"}obvious{"} cause is the presence of drug resistant strains, missed in conventional testing because of heterogeneity of resistance, special test requirements or emergence during treatment. A second large group of causes is due to atypical forms, whereas a third cause is due to tolerance. A fourth group of causes may be termed invironmental factors, and this includes drug inactivation, bioconversion or antagonism, often a result of the infection itself. [References: 55]",
keywords = "Animals, Anti-Bacterial Agents/me [Metabolism], Anti-Bacterial Agents/tu [Therapeutic Use], Bacteria/en [Enzymology], Bacterial Infections/dt [Drug Therapy], Biotransformation, Drug Resistance, Microbial, Humans, L Forms",
author = "Acar, {J. F.} and Sabath, {L. D.}",
year = "1978",
language = "English (US)",
volume = "14",
pages = "86--91",
journal = "Scandinavian Journal of Infectious Diseases Supplement",
number = "14",

}

TY - JOUR

T1 - Bacterial persistence in vivo

T2 - resistance or tolerance to antibiotics.

AU - Acar, J. F.

AU - Sabath, L. D.

PY - 1978

Y1 - 1978

N2 - The in vivo persistence of bacteria in spite of "adequate" therapy may be due to a variety of causes or factors. The most "obvious" cause is the presence of drug resistant strains, missed in conventional testing because of heterogeneity of resistance, special test requirements or emergence during treatment. A second large group of causes is due to atypical forms, whereas a third cause is due to tolerance. A fourth group of causes may be termed invironmental factors, and this includes drug inactivation, bioconversion or antagonism, often a result of the infection itself. [References: 55]

AB - The in vivo persistence of bacteria in spite of "adequate" therapy may be due to a variety of causes or factors. The most "obvious" cause is the presence of drug resistant strains, missed in conventional testing because of heterogeneity of resistance, special test requirements or emergence during treatment. A second large group of causes is due to atypical forms, whereas a third cause is due to tolerance. A fourth group of causes may be termed invironmental factors, and this includes drug inactivation, bioconversion or antagonism, often a result of the infection itself. [References: 55]

KW - Animals

KW - Anti-Bacterial Agents/me [Metabolism]

KW - Anti-Bacterial Agents/tu [Therapeutic Use]

KW - Bacteria/en [Enzymology]

KW - Bacterial Infections/dt [Drug Therapy]

KW - Biotransformation

KW - Drug Resistance, Microbial

KW - Humans

KW - L Forms

UR - http://www.scopus.com/inward/record.url?scp=0017795624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017795624&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 86

EP - 91

JO - Scandinavian Journal of Infectious Diseases Supplement

JF - Scandinavian Journal of Infectious Diseases Supplement

IS - 14

ER -